FacebookTwitterGoogle+RedditEmail

What’s the Matter with Oregon?

by FRED GARDNER

“In Corvallis, a very progressive community, there is virtually no doctor who will recommend cannabis for cancer pain or for severe nausea or AIDS.”

-Nurse Ed Glick

Ed Glick was fired April 18 from his job as an acute-care nurse at Samaritan Regional Mental Health Center in Corvallis. He had been employed there for 12 years. The pretext was his refusal to take a drug test. The real reason, Glick thinks, was the pressure he’d been putting on the Oregon Medical Marijuana Program to accept patients with psychiatric diagnoses.

The Oregon Medical Marijuana Act was created by voter initiative in 1998. Unlike California’s law, passed in ’96, which authorizes doctors to recommend marijuana for “any… condition for which marijuana provides relief,” the OMMA created a finite list of qualifying conditions: Cachexia (wasting), Cancer, Glaucoma, HIV+/AIDS, Nausea, Severe Pain, Seizures, including but not limited to epilepsy, and Persistent muscle spasms, including but not limited to those caused by multiple sclerosis.

After OMMA passed, Glick began seeing patients at Samaritan who said they were self-medicating with cannabis to ease various psychiatric symptoms. He would encounter the same people at the Compassion Center in Eugene, where he worked as a volunteer helping patients enroll in the state program. “We assist these people by trying to find a physical correlation to their psychiatric symptom,” Glick explains. “For example, if they’re having PTSD symptoms they might be sick and have physical symptoms.”

Glick attempted to determine how many people were treating psychiatric symptoms by reviewing 172 randomly selected charts. He presented his results at the Patients Out of Time Conference April 8:

“The average patient age was 43. All the patients were registered in OMMA; 95% were registered for pain. (A very large percentage of Oregon registrants are pain patients. Some 40% had multiple qualifying conditions (not including psychiatric) -physical pain and nausea, for example. Pain with spasticity -they often go together.

“The results: 64% of the patients in the survey showed some kind of significant psychiatric benefit; 39% reported insomnia relief; 5% reported PTSD symptom relief, many of them veterans who go to the VA hospital in Roseburg and are denied. The VA doctors tell them ‘No, I can’t. I’ll lose my DEA license.’ They just don’t want to stand up to it -although they’re beginning to refer patients to us, which is kind of interesting.

“Anxiety, 11%; depressive symptoms, 11%; 15% of the cohort reported that they were using cannabis to decrease the side effects of medications; 56% reported reduced use of medications.

“What these patients report to me is that they’re sick and tired of Vioxx and they’re sick and tired of Flexeril, Vicodin -people are literally sick of these drugs. They can’t sleep, they can’t function, they’re drugged up, they don’t have any enjoyment of life. When they start using cannabis they leave off the Vioxx and they leave off the Vicodin. Vicodin has a place, but for long-term pain management it is really poor. Appetite stimulation -tremendously important for people who are in pain all the time- was 20%.

“I put the survey together as a request to the Oregon Department of Human Services to reconvene the Debilitating Conditions Advisory Panel, which I was a member of in 2000. At that time nine patients had submitted requests to include psychiatric conditions to the list. The state health officer did a fairly good job of bringing together the panel, but the whole thing was skewed from the outset by political manipulation by the governor’s office and by the head of the Department of Health Services. The information that they would allow us to consider had to be filtered through rules stating that if it’s not a double-blind, peer-reviewed clinical trial, it doesn’t get a lot of evidentiary weight.

“We were not allowed to give much weight to patients’ reports. And of course there was no relevant double-blind, peer-reviewed clinical trial. So the panel was set up to fail. A few patients came in and gave very compelling testimonials. And then out of nowhere came a whole bunch of medical experts -psychiatrists from Oregon Health Sciences University and the National Alliance for the Mentally Ill- and they just had fits. “This is quackery,” they said.

“The only person who even differentiated between affective depressive-type disorders and schizophrenic thought disorders was one of the patients. None of the doctors even made any differentiation between these two completely different sets of medical problems. After a long, protacted time we all wrote our comments out, and there was a vote, and we voted to add affective disorders -severe agitation and depressive symptoms. Didn’t happen. They finally did add Alzheimer’s agitation. [Fewer than 50 patients have qualified to date for Alzheimer’s agitation.]

“So, five years later I brought in the study I’d done with OMMP registrants and asked them to reconvene the Debilitating Conditions Panel based on this new evidence showing that indeed there is some psychiatric effect that people are getting from their cannabis use. And they rejected the request with a ‘summary denial.’

“Then Lee Berger, an attorney in Portland, asked if I’d be willing to sue the Department of Human Services’ OMMP and I said yes. We filed our petition for judicial review in February -a formal request ‘to Add Clinical Depression, Depressive Symptoms, Post-Traumatic Stress Disorder (PTSD), Severe Anxiety, Agitation and Insomnia, to Those Diseases and Conditions Which Qualify as “Debilitating Medical Conditions” under the Oregon Medical Marijuana Act.’ And it worked! I can’t believe it!

“We got word in late March that, because the OMMP doesn’t really want to go to court, they’ve decided to kind of sue for peace. All we’re asking is that they reconvene a panel to evaluate these conditions. So, we’re in the process of negotiating with them to get this thing back on track.

“We want to close some of the loopholes that allow them to skew the evidence base. It’s pretty clear that there are a lot of patients who are using cannabis for insomnia, for mood stabilizing, and for peace. Just for a a very simple, elemental peace, especially with chronic diseases like severe chronic pain. Cannabis is actually a miracle drug for pain, in my opinion.

“There’s no question the last thing the pharmacy industry wants is millions and millions of Americans growing and using their own medicine that covers such a wide array of diseases.”

Glick was fired 10 days after giving this account to Patients Out of Time. Perhaps someone at the Oregon Health Sciences University, the dominant institution in Corvallis, did not like the effrontery of a Samaritan nurse criticizing their prestigious “experts.”

 

Washburn Can’t Get His Job Back

The Oregon Supreme Court has ruled against Robert Washburn, a Klamath Falls millworker fired by Columbia Forest Products in 2001 after he tested positive for marijuana. Washburn had a card from the OMMP and used marijuana at home (not “in” the workplace) for insomnia stemming from muscle pain. Before getting his card in 1999 Washburn had been using prescription painkillers. He says that marijuana is more effective and exerts no adverse effects. He requested that the company give him a test to determine if he was actually impaired on the job (rather than one that detects metabolites in the urine). This, his lawyer argued, would be a reasonable accommodation under Oregon’s statute protecting the disabled from discrimination in the workplace. When the company refused, Washburn sued for reinstatement and back pay.

A Multnomah County Circuit Court judge ruled against Washburn, citing a clause in OMMA saying the act shall not be construed to require “an employer to accommodate use of medical marijuana in the workplace.” The Court of Appeals then ruled for Washburn and Columbia Forest Products took the case to the state supreme court, which heard arguments in November. Now the Supremes have ruled unanimously that Washburn does not qualify as disabled because the prescription drugs enabled him to sleep (albeit less well and with more side effects than marijuana).

According to Chief Justice Paul De Muniz, Washburn’s pain-related sleep problems did not constitute a “substantial limitation” justifying the use of marijuana. In a concurring opinion, Justice Rives Kistler cited the U.S. Supreme Court ruling in the Raich case that the federal Controlled Substances Act prohibits marijuana possession and use, even for medical purposes.

The state supreme court ruling against Washburn is “narrow” in the sense that workers with more severe disabilities might yet assert the rights he was denied. But attorney Phil Lebenbaum, expressed concern that the ruling limits the definition of a disability, and may affect workers in cases having nothing to with marijuana.

Willamette Weak

Reform advocate Don DuPay, running for Sheriff of Multnomah county, got 31% of the vote (on a budget of $485), despite being dissed by the Portland media. DuPay is a former Portland cop who has worked extensively with recovering addicts and alcoholics. “Willamette Week was the first paper to talk to me,” he recounts. “I spent an hour talking to four of their reporters, explaining my ideas about community policing, getting rid of tasers, getting rid of the SWAT-team-style uniforms, creating a Wapato Treatment center, giving back $30,000 of my salary to social services. ‘Thank you Mister DuPay for coming in,’ they said, ‘And by the way, what kind of a car do you drive?’

“What they printed was that I was a 69-year-old marijuana-smoking grandfather with a cult-following from the Cannabis Common Sense TV Show. Is that all those reporters heard? They went on to endorse a write-in candidate unqualified to take office.” Alternative media, indeed.
Can’t You Say Something Positive?

Bees and butterflies were sighted in the Willamette Valley on our O’Shaughnessy’s distribution run. This may mean that the organic movement is reducing the tonnage of pesticides and herbicides drenching that luscious topsoil D.O., the osteopaths’ journal, has a cover story on cannabis in which Philip Leveque (whose license was revoked by the Oregon Board of Medical Examiners) is one of two advocates for the herb in a debate against 12 nay-sayers. Leveque says he’s heard that some 200 Oregon osteopaths have issued letters of approval for their patients to medicate with cannabis.

FRED GARDNER is the editor of O’Shaughnessy’s Journal of the California Cannabis Research Medical Group. He can be reached at: fred@plebesite.com

 

 

More articles by:

Fred Gardner is the managing editor of O’Shaughnessy’s. He can be reached at fred@plebesite.com

CounterPunch Magazine

minimag-edit

bernie-the-sandernistas-cover-344x550

zen economics

Weekend Edition
July 28, 2017
Friday - Sunday
Diana Johnstone
Collateral Damage: U.S. Sanctions Aimed at Russia Strike Western European Allies
Jim Kavanagh
Donald the Destroyer: Assessing the Trump Effect
Carl Boggs
The Other Side of War: Fury and Repression in St. Louis
Eva Golinger
There is Still Time to Prevent Civil War in Venezuela
Anthony DiMaggio
“A Better Deal”? Dissecting the Democrats’ “Populist” Turn in Rhetoric and Reality
Conn Hallinan
Middle East Chaos
Mumia Abu-Jamal
James Baldwin: Word Warrior
Joshua Frank
The Fire Beneath: Los Angeles is Sitting on a Ticking Time Bomb
Myles Hoenig
It Wasn’t Russia, It was the Green Party!
Andrew Levine
Enter Scaramouche, Stage Right
Brian Cloughley
Time to Get Out of Afghanistan
Gary Leupp
The Trump Revolution Devouring Its Own Children
John Wright
Trump’s Hezbollah Gaff Was No Gaff
Alan Jones
“Finland Station” and the Struggle for Socialism Today
Robert Hunziker
Plastic Chokes the Seas
Eric Draitser
Enough Nonsense! The Left Does Not Collaborate with Fascists
Vijay Prashad
The FBI vs. Comrade Charlie Chaplin
Jane LaTour
Danger! Men Working
Yoav Litvin
The Unbearable Lightness of Counterrevolution
Charles Derber
Universalizing Resistance: How to Trump Trump
Gregory Barrett
Two Johnstones and a Leftish Dilemma: Nationalism vs. Neoliberalism
Joseph Natoli
Choosing the ‘Arteries that Make Money’
CJ Hopkins
Intersectionalist Internet Blues
Pepe Escobar
China and India Torn Between Silk Roads and Cocked Guns
Ralph Nader
Can the World Defend Itself From Omnicide?
Howard Lisnoff
Agape While Waltzing at the Precipice
Musa Al-Gharbi
Want to Shake Up Status Quo? Account for the Default Effect
Angela Kim
North Korean Policy Must Focus on Engagement Not Coercion
Hiroyuki Hamada
Delivering Art in the Empire
David Macaray
Talking Union
Binoy Kampmark
Refugee Conundrums: Resettlement, the UN and the US-Australia Deal
Robert Koehler
Opening Gitmo to the World
David Jaffee
No Safe Space for Student X
Thomas Knapp
The State is at War — With the Future
David Swanson
What’s Missing from Dunkirk Film
Winslow Myers
There Is Still Time, Brother
Robert J. Burrowes
Biological Annihilation on Earth Accelerating
Frederick B. Hudson – Dr. Junis Warren
Robot Scientists Carry Heavy Human Hearts 
Randy Shields
Not My Brother’s Reefer
Sam Lichtman
Where are the Millennials?
Louis Proyect
Death Race: the Cruelties of the Iditarod
Charles R. Larson
Review: Norman Lock’s A Fugitive in Walden Woods
July 27, 2017
Edward Curtin
The Deep State, Now and Then
Melvin Goodman
The Myth of American Exceptionalism
Nozomi Hayase
From Watergate to Russiagate: the Hidden Scandal of American Power
FacebookTwitterGoogle+RedditEmail